Transcriptional Regulation Of Gene Expression: Dietary Sialic Acid Interaction In Brain Cognitive Development
Funder
National Health and Medical Research Council
Funding Amount
$46,646.00
Summary
In 2004, 8.2% of Australian live births were preterm with poor long-term cognitive outcomes. Sialic acid (SA), a key component of both human milk oligosaccharides and neural tissues, plays a role in neuronal development. This study will examine the mechanisms of how dietary SA or active learning interacts with genes during brain development. It will benefit the neonatal care of all children, particularly those born premature and ultimately, the quality of life of many Australians.
A Cluster Randomised Trial To Test A Systems Based Collaborative For Type 2 Diabetes Among Indigenous Australians
Funder
National Health and Medical Research Council
Funding Amount
$1,855,936.00
Summary
Type 2 diabetes is a condition which contibutes significantly to Indigenous disability and premature death. Increasing numbers of Indigenous Australians are developing Type 2 diabetes. To date there has been limited research on systematic approaches to improving screening and managment outcomes for Type 2 diabetes. This important research will test the effectiveness of a systems based collaborative approach to improve health outcomes for people with Type 2 diabetes.
It is known that about 10% of patients over the age of 55 have difficulty with cognition and thinking 3 months after surgery and anaesthesia. Over 2 million operations involving anaesthesia are administered in Australia every year and increasingly the patients are elderly and thus exposed to the risk of cognitive decline after surgery. We have preliminary data showing that people who have mild changes in cognitive function before the surgery (known as mild cognitive impairment) are susceptible t ....It is known that about 10% of patients over the age of 55 have difficulty with cognition and thinking 3 months after surgery and anaesthesia. Over 2 million operations involving anaesthesia are administered in Australia every year and increasingly the patients are elderly and thus exposed to the risk of cognitive decline after surgery. We have preliminary data showing that people who have mild changes in cognitive function before the surgery (known as mild cognitive impairment) are susceptible to further cognitive decline after anaesthesia and surgery. In order to explore the relationship between preoperative cognitive function and postoperative cognitive decline we plan to measure cognition in patients scheduled for elective hip replacement surgery. This is done by asking patients to complete a standard battery of cognitive tests. We will be then able to identify those patients who already have mild cognitive impairment before surgery and by repeated testing after the operation will be able to demonstrate if preoperative cognitive status is a determinant of postoperative cognitive dysfunction. The primary aim of the research is to test whether cognitive impairment before surgery leads to cognitive deficit after surgery in patients over the age of 65 undergoing total hip replacement surgery. The study will also establish the prevalence of pre-operative mild cognitive impairment and the magnitude of postoperative cognitive dysfunction after surgery in this patient group. The study will explore the relationship between preoperative cognitive status and postoperative cognitive deficit , providing information about the incidence, natural history and risk factors of postoperative cognitive deficit. This work will enable further research to isolate specific causative factors and identify therapeutic and prophylactic strategies.Read moreRead less
Cardiac Intervention, Surgery And Cognitive Outcome (CISCO) Study
Funder
National Health and Medical Research Council
Funding Amount
$367,739.00
Summary
We propose to investigate the association between the presence of coronary artery disease and changes in brain function after therapeutic interventions. Patients undergoing surgery for coronary heart disease are prone to experience changes in mental function and higher level thought processes (cognition) after surgery, especially if they are elderly. As the population ages this is becoming a more significant problem. There is some limited evidence that this particular group of patients has a hig ....We propose to investigate the association between the presence of coronary artery disease and changes in brain function after therapeutic interventions. Patients undergoing surgery for coronary heart disease are prone to experience changes in mental function and higher level thought processes (cognition) after surgery, especially if they are elderly. As the population ages this is becoming a more significant problem. There is some limited evidence that this particular group of patients has a higher incidence of cognitive impairment than the normal population even before they present for surgery, because cardiovascular disease has also been shown to be associated with changes in cognition. To investigate this, we will measure cognitive status in patients over the age of 55 who have coronary artery disease and are being investigated with coronary angiography. This will provide an indication of the baseline cognitive status in patients presenting with coronary vascular disease. We will use validated neuropsychological tests that have been used to assess potsoperative cognitive decline. These tests are sufficiently sensitive to detect subtle changes in a number of areas of thought processing (cognitive domains) and thus identify those subjects who have cognitive impairment. Patients will then go on to be treated by surgery or angioplasty. We will continue to test these patients at time intervals for 3 months in order to track the changes in cognition in each treatment group. Thus we will be in the position to compare how these modalities of treatment for heart disease impact on patients mental function and cognition. In addition we will be able to tell whether a 'recovery' period might be of benefit following coronary angiography. If we are able to demonstrate different cognitive outcomes from different treatments and also an association with pre-existing cognition, this will guide clinical decision making to minimise harm to the brain.Read moreRead less
The Cognitive Impact Of Opioids During Chronic Administration
Funder
National Health and Medical Research Council
Funding Amount
$416,024.00
Summary
Many people are now being prescribed opioid drugs for long periods of time, mainly for the treatment of chronic pain. These drugs can adversely affect the person's ability to drive a car, hold down a job, and perform normal functions of daily living. This project will investigate what types of impairment are produced by these drugs and how the drugs can best be used so as to minimise the effects on patients.
Effects Of Oestrogen On Mood, Memory And Quality Of Life Of Women Aged 70 Years Or Over
Funder
National Health and Medical Research Council
Funding Amount
$170,990.00
Summary
Oestrogen has a number of actions that extend well beyond the regulation of the reproductive cycle and sexual behaviour. The results of recent studies indicate that oestrogen may influence mood and a number of intellectual abilities such as memory and language. In addition, oestrogen replacement therapy seems to reduce the risk of Alzheimer's disease (the most frequent cause of dementia in Western societies) amongst postmenopausal women. The present study aims to: (1) investigate the association ....Oestrogen has a number of actions that extend well beyond the regulation of the reproductive cycle and sexual behaviour. The results of recent studies indicate that oestrogen may influence mood and a number of intellectual abilities such as memory and language. In addition, oestrogen replacement therapy seems to reduce the risk of Alzheimer's disease (the most frequent cause of dementia in Western societies) amongst postmenopausal women. The present study aims to: (1) investigate the association of depression and memory performance with physiological levels of oestrogen in women aged 70 years or over; and (2) investigate the evolution of depression and memory scores in old women treated with oestrogen replacement therapy as compared to placebo. The results of the present study may have important implications in the prevention and management of two of the most relevant mental health disorders of later life: depression and Alzheimer's disease.Read moreRead less
What Is The Burden Of Dementia In Urban Dwelling Indigenous Australians?
Funder
National Health and Medical Research Council
Funding Amount
$1,571,527.00
Summary
The main aim of this research project is to determine what proportion of Aboriginal people aged 45 years and older who live in urban areas of NSW, have dementia. We hope to establish what types of dementia occur amongst Aboriginal people, what the causes are, and how we can best measure dementia. We will also focus on what types of problems dementia causes for both people with the condition and their carers. What is the meaning of dementia for Aboriginal people themselves?
The ability to monitor one's cognitive performance deteriorates with normal ageing, and is particularly affected in a range of clinical conditions of older age, such as Parkinson's Disease, where it is a predictor of a poor prognostic outcome. This project aims to clarify the effects of age on cognitive and neural processes underlying performance monitoring, as an important first step to improving interventions for age-related impairments, including those accompanying neurodegenerative diseases.
Cognitive Function And Fatigue In Cancer Patients After Chemotherapy
Funder
National Health and Medical Research Council
Funding Amount
$246,412.00
Summary
Many patients complain of tiredness after chemotherapy and some experience problems with memory, concentration, thinking and other aspects of mental function. Studies have confirmed that some women with breast cancer suffer these effects after chemotherapy and that they can last a long time. Although generally subtle they can affect quality of life and ability to function. Little is known about the causes of these side-effects. Possible causes include blood clotting in small vessels of the brain ....Many patients complain of tiredness after chemotherapy and some experience problems with memory, concentration, thinking and other aspects of mental function. Studies have confirmed that some women with breast cancer suffer these effects after chemotherapy and that they can last a long time. Although generally subtle they can affect quality of life and ability to function. Little is known about the causes of these side-effects. Possible causes include blood clotting in small vessels of the brain and release of molecules called cytokines, as a result of chemotherapy. Hormonal changes and induced menopause might also contribute to these effects in women. Here we propose to evaluate men and women who either receive chemotherapy to prevent recurrence of colorectal cancer, or who are followed without such treatment after surgery. Patients will complete a questionnaire that assesses their level of fatigue and participate in tests of mental functioning, before, during and at intervals after treatment. Possible causes of fatigue and cognitive problems will be studied by measuring products in the blod that indicate blood clotting, levels of cytokine molecules that might cause these symptoms and levels of sex hormones in both men and women. This may lead to further studies to help reduce the burden of fatigue and cognitive impairment from chemotherapy. The goals of our study are to provide comphrehensive information about important side-effects of cancer treatment and to examine the mechanisms that may cause them. This information is important for supporting people living with cancer and for subsequent research to develop interventions that will promote healthy lifestyles during and after treatment for cancer.Read moreRead less